You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ER Metastatic Breast Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Charleston (OPC)

Terminated
  • Breast Cancer
  • Charleston, South Carolina
    Medical University of South Carolina
Aug 9, 2022

Breast Cancer Stage IV Trial in Irvine (Gallium-68)

Recruiting
  • Breast Cancer Stage IV
  • Irvine, California
    Hoag Memorial Hospital Presbyterian
May 26, 2023

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage I Trial in Shanghai (FWD1802, palbocilib)

Recruiting
  • Metastatic Breast Cancer
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 26, 2023

Metastatic Breast Cancer Trial (Estradiol)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Feb 6, 2023

Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial (OP-1250, Fulvestrant, Anastrozole)

Not yet recruiting
  • Breast Cancer
  • +4 more
  • (no location specified)
Aug 31, 2023

Metastatic Breast Cancer, Triple Negative Breast Cancer, Estrogen-receptor-low Breast Cancer Trial in Carmel, Indianapolis

Not yet recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Carmel, Indiana
  • +2 more
Apr 27, 2023

Advanced or Metastatic Breast Cancer Trial in Paris (Milademetan, Patient Reported Outcomes (PROs) and Health-Related Quality of

Not yet recruiting
  • Advanced or Metastatic Breast Cancer
  • Milademetan
  • Patient Reported Outcomes (PROs) and Health-Related Quality of Life (HRQOL)
  • Paris, France
    Institut Curie
Jun 27, 2023

ER+, HER2- Advanced Breast Cancer, Metastatic Breast Cancer Trial in Luoyang, Shanghai (TFX06 tablet)

Recruiting
  • ER+, HER2- Advanced Breast Cancer
  • Metastatic Breast Cancer
  • TFX06 tablet
  • Luoyang, Henan, China
  • +1 more
Jun 25, 2023

Estrogen-receptor-positive Breast Cancer, HER2/Neu-Negative Breast Cancer, Advanced Breast Cancerv Trial in Chicago

Not yet recruiting
  • Estrogen-receptor-positive Breast Cancer
  • +3 more
  • elacestrant, palbociclib, abemaciclib, ribociclib
  • Chicago, Illinois
    Northwestern University
Sep 25, 2023

Premenopausal Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer Trial in Taipei City (Goserelin, Fulvestrant,

Recruiting
  • Premenopausal Breast Cancer
  • +2 more
  • Taipei City, Taiwan
    Department of Oncology, National Taiwan University Hospital
Feb 7, 2023

Metastatic Breast Cancer Trial (Olaparib, 17b-estradiol)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Jun 2, 2023

Breast Cancer Trial (RP-6306, Gemcitabine, Observation)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jan 26, 2023

Breast Cancer Trial in United States (Neratinib, Fulvestrant)

Active, not recruiting
  • Breast Cancer
  • Indianapolis, Indiana
  • +5 more
Mar 2, 2022

Metastatic Breast Cancer Trial in Springfield, Rochester, Lebanon (17B-estradiol, Letrozole, Anastrozole)

Active, not recruiting
  • Metastatic Breast Cancer
  • Springfield, Massachusetts
  • +2 more
Nov 1, 2022

Assessed by 18F-FES PET/CT in MBC With ER-positive Primary Tumor

Recruiting
  • Breast Cancer
    • Shanghai, Shanghai, China
      Biyun Wang, MD
    Apr 5, 2023

    Metastatic Breast Cancer Trial in United States (Enzalutamide, Mifepristone, TPC)

    Recruiting
    • Metastatic Breast Cancer
    • Birmingham, Alabama
    • +5 more
    Oct 19, 2023

    Breast Cancer Trial in Sydney ([68Ga]GA-NeoB)

    Recruiting
    • Breast Cancer
    • Sydney, New South Wales, Australia
      St Vincent's Hospital
    May 22, 2023

    ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer, a Germline or Somatic BRCA Mutation, or a

    Recruiting
    • ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer
    • a Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI Status
    • Montpellier, France
    • +1 more
    Nov 16, 2022

    Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer Trial

    Not yet recruiting
    • Hormone Receptor-positive Breast Cancer
    • +2 more
    • Nashville, Tennessee
      Sarah Cannon Research Institute
    Oct 5, 2022

    Metastatic Breast Cancer Trial (Lasofoxifene in combination with abemaciclib, Fulvestrant in combination with abemaciclib)

    Not yet recruiting
    • Metastatic Breast Cancer
    • Lasofoxifene in combination with abemaciclib
    • Fulvestrant in combination with abemaciclib
    • (no location specified)
    Jan 25, 2023

    Cyclin-dependent Kinase 4/6 Inhibitors on Body Composition in

    Recruiting
    • Breast Cancer
    • CT scans
    • DEXA scan
    • Bronx, New York
      Montefiore Medical Center
    Jan 6, 2023

    Breast Cancer Trial in Sarasota, Nashville (AC699)

    Recruiting
    • Breast Cancer
    • Sarasota, Florida
    • +1 more
    Jan 3, 2023

    ER+, HER2-, Metastatic Breast Cancer Trial in China (AZD9833, AZD9833 with palbociclib, AZD9833 with everolimus)

    Recruiting
    • ER+, HER2-, Metastatic Breast Cancer
    • Beijing, China
    • +5 more
    Jan 13, 2023

    TNBC - Triple-Negative Breast Cancer Trial (Alkaline Glucosodiene Molecules)

    Not yet recruiting
    • TNBC - Triple-Negative Breast Cancer
    • Alkaline Glucosodiene Molecules
    • (no location specified)
    Jul 14, 2023

    ER-positive Breast Cancer, HER2-negative Breast Cancer, Metastatic Cancer Trial in Madison, Milwaukee (Onapristone, Fulvestrant)

    Recruiting
    • ER-positive Breast Cancer
    • +2 more
    • Madison, Wisconsin
    • +1 more
    Jul 7, 2022